An observational study in Pulmonary Vascular Sensibility in Hypoxia, Hypercapnia and Hypoxia and Hypercapnia, sponsored by University Hospital, Strasbourg, France. Completed at 1 site in France. Open to male participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2014-10-15.
Sponsored by University Hospital, Strasbourg, France · Observational
The aim of this study is to describe the pulmonary hemodynamic evolution at rest and during a short constant load exercise in 4 conditions :
1,231 studies on the registry are indexed under Hypoxia; 241 are open to participants now.
This study's enrollment of 8 is below the median of 67 across 335 observational studies indexed under Hypoxia.
Browse Hypoxia studies →University Hospital, Strasbourg, France is the lead sponsor of 966 studies on the registry; 342 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Healthy volunteers
Exclusion criteria:
Device: Hypoxia inhalation (Altitrainer NP 190)
Device: Hypercapnia inhalation (Altitrainer NP 190)
Device: Hypoxia and hypercapnia (Altitrainer NP 190)
Hypercapnia inhalation using an Altitrainer NP 190
Hypoxia and hypercapnia inhalation using an Altitrainer NP 190
Hypoxia inhalation using an Altitrainer NP 190
Systolic Artery Pulmonary Pressure(sPAP) (echocardiography, Cardiac output (impedancemetry), Cardiorespiratory parameters
At rest and during exercise for each condition
Time frame: at the end of the 30th minutes constant load exercise
Dyspnea and muscle leg discomfort using a Borg Scale
In each conditions at rest and during exercise
Time frame: at the end of the 30th minutes constant load exercise
This study is completed, as verified in Oct 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Strasbourg, France